Medical News / Coverage ASRS 2019: FAi Insert for Treatment of Non-Infectious Posterior Segment Uveitis

New data on the 36-month outcomes of injectable fluocinolone acetonide intravitreal insert (FAi) on recurrences of non-infectious posterior segment uveitis was presented on Tuesday afternoon at the 2019 American Society of Retina Specialists Annual Meeting in Chicago, IL. Quan Dong Nguyen, MD, MSc, professor of ophthalmology at Stanford University Medical Center, presented the results of the study, which found that treatment with a single intravitreal injection of the FAi provided anti-inflammatory treatment for 3 years in patients with non-infectious uveitis affecting the posterior segment of the eye. Source: MDmag By reading more or clicking on the link below, you are leaving this site and going to another site run by another organization

read more

With fixed incomes a reality for many elderly patients, finding less expensive alternatives to current therapies ... read more
Despite not being a physician, Lawrence Hoffheimer, a former healthcare attorney who practice in Washington D.C. ... read more
Heading into the 2019 American Society of Retina Specialists Annual Meeting, sessions and studies pertaining to ... read more
Results of a new study show that receiving same day intravitreal anti-VEGF treatments was highly preferred ... read more